TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
MGX

Metagenomi, Inc.

Healthcare · Biotechnology

1.20$ +1.8% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement MGX
Line item 2021 2022 2023 2024 2025
– +6,978.2% +160.2% +16.8% -51.8%
– +347.8% +5,347.4% -94.3% -1.7%
– – -421.0% – -62.0%
– +198.0% +118.8% +15.7% -13.5%
– +92.6% +54.2% +11.0% -16.3%
– +152.5% -52.0% +389.5% -17.9%
– – – – –
– -67.5% -100.0% – –
– – – – –
– +739.5% +212.5% -168.7% –
– – – – –
– – – – –

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?